Chronic lymphocytic leukemia (CLL), the most frequent adult leukemia in the Western world, is notable for its highly variable clinical course. Some patients may progress early, while others may have ...
The ecto-enzyme CD38 is gaining momentum as a novel therapeutic target for patients with hematological malignancies, with several anti-CD38 monoclonal antibodies in clinical trials with promising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results